Marrone Bio Innovations Inc
NASDAQ:MBII
Marrone Bio Innovations Inc
NASDAQ:MBII
Price:
0.8 USD
Market Closed
Updated:
May 18, 2024
Marrone Bio Innovations Inc
Operating Expenses
|
Marrone Bio Innovations Inc
Operating Expenses Peer Comparison
Comparables:
CF
FMC
CTVA
SMG
MOS
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Marrone Bio Innovations Inc
NASDAQ:MBII
|
Operating Expenses
-$43.9m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
CF Industries Holdings Inc
NYSE:CF
|
Operating Expenses
-$322m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
FMC Corp
NYSE:FMC
|
Operating Expenses
-$1.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Corteva Inc
NYSE:CTVA
|
Operating Expenses
-$5.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Operating Expenses
-$543.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
|
|
Mosaic Co
NYSE:MOS
|
Operating Expenses
-$973m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-3%
|
See Also
What is Marrone Bio Innovations Inc's Operating Expenses?
Operating Expenses
-43.9m
USD
-43.9m
USD
Based on the financial report for Mar 31, 2022, Marrone Bio Innovations Inc's Operating Expenses amounts to -43.9m USD.
What is Marrone Bio Innovations Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-9%
-9%
Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for Marrone Bio Innovations Inc have been -12% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
